Burning Rock Biotech

BNR · NASDAQ

$12.66+$0.37 (+3.01%)TodayMarket closed ·
Prev close $12.29

Who owns BNR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 4.1% of BNR’s shares.

  • Kynam Capital Management LP1.2%
  • Northern Light Venture Capital1.0%
  • Lyfe Capital0.8%
  • China Merchants Bank Co Ltd0.4%
  • Next 6 largest institutions0.7%
  • All other shareholders95.9%
Top institutional holders of BNR
HolderShares% of shares
Kynam Capital Management LP1.24M1.17%
Northern Light Venture Capital1.05M1.00%
Lyfe Capital833.84K0.79%
China Merchants Bank Co Ltd462.99K0.44%
Quantum Boundary Holdings Ltd353.92K0.34%
CRCM L.P.212.00K0.20%
Renaissance Technologies LLC52.84K0.05%
Truvalue Asset Management Co., Ltd.44.09K0.04%
Morgan Stanley & Co. LLC43.12K0.04%
Amova Asset Management Co., Ltd.29.72K0.03%

Largest mutual fund holders

Top mutual fund holders of BNR
HolderShares% of shares
Truvalue Global Medical Biology Equity Seed Fund (QDII)44.09K0.04%
Amova Global All Bio Genome Equity Fund (Annual Settlement)22.11K0.02%
Amova Global Genome Equity Fund (Semi-annual Settlement)4.33K0.00%
Fidelity NASDAQ Composite Index Fund4.22K0.00%
Invesco Golden Dragon China ETF3.81K0.00%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $6.18M (7 trades) of BNR on the open market, with no sales.

Latest BNR insider transactions
InsiderTypeSharesValue
Han YushengBuy24.90K$199.09K
Han YushengBuy250.00K$2.00M
Han YushengBuy5.99K$44.92K
Han YushengBuy104.65K$779.67K
Han YushengBuy111.11K$999.96K
Han YushengBuy210.00K$1.94M
Han YushengBuy24.76K$216.39K

Short interest

Settled Sep 30, 2026

Shares short
41.42K
Days to cover
1.00
% of shares outstanding
0.04%
Average daily volume
41.87K
Change since last report
+5.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.